Clofilium, a potassium channel blocker, induces apoptosis of human promyelocytic leukemia (HL-60) cells via Bcl-2-insensitive activation of caspase-3
- 29 November 1999
- journal article
- Published by Elsevier BV in Cancer Letters
- Vol. 147 (1-2), 85-93
- https://doi.org/10.1016/s0304-3835(99)00280-3
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Mitochondria and ApoptosisScience, 1998
- Caspases: killer proteasesTrends in Biochemical Sciences, 1997
- Screening for novel drug effects with a microphysiometer: A potent effect of clofilium unrelated to potassium channel blockadeLife Sciences, 1997
- Bcl-2 and the ICE family of apoptotic regulators: making a connectionCurrent Opinion in Genetics & Development, 1997
- Molecular Ordering of the Cell Death Pathway: Bcl-2 AND Bcl-xL FUNCTION UPSTREAM OF THE CED-3-LIKE APOPTOTIC PROTEASESPublished by Elsevier BV ,1996
- Life, death, and the pursuit of apoptosis.Genes & Development, 1996
- The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activationCell, 1995
- RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell deathCell, 1995
- Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICENature, 1994
- Inhibition of calmodulin and protein kinase C by amiodarone and other class III antiarrhythmic agentsCardiovascular Drugs and Therapy, 1989